Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 34.17 USD 1.24%
Market Cap: 1.7B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Immunocore Holdings PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunocore Holdings PLC
Research & Development Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
GNS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Immunocore Holdings PLC
NASDAQ:IMCR
Research & Development
-ÂŁ163.5m
CAGR 3-Years
-30%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Research & Development
-$124.4m
CAGR 3-Years
-137%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Research & Development
-ÂŁ117m
CAGR 3-Years
-105%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Research & Development
-$122.3m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Research & Development
-$167.9m
CAGR 3-Years
-59%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Immunocore Holdings PLC's Research & Development?
Research & Development
-163.5m GBP

Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Research & Development amounts to -163.5m GBP.

What is Immunocore Holdings PLC's Research & Development growth rate?
Research & Development CAGR 5Y
-14%

Over the last year, the Research & Development growth was -83%. The average annual Research & Development growth rates for Immunocore Holdings PLC have been -30% over the past three years , -14% over the past five years .

Back to Top